Cargando…
Quantifying the pharmacology of antimalarial drug combination therapy
Most current antimalarial drugs are combinations of an artemisinin plus a ‘partner’ drug from another class, and are known as artemisinin-based combination therapies (ACTs). They are the frontline drugs in treating human malaria infections. They also have a public-health role as an essential compone...
Autores principales: | Hastings, Ian M., Hodel, Eva Maria, Kay, Katherine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036534/ https://www.ncbi.nlm.nih.gov/pubmed/27604175 http://dx.doi.org/10.1038/srep32762 |
Ejemplares similares
-
Incorporating Stage-Specific Drug Action into Pharmacological Modeling of Antimalarial Drug Treatment
por: Hodel, Eva Maria, et al.
Publicado: (2016) -
Pharmacological considerations in the design of anti-malarial drug combination therapies – is matching half-lives enough?
por: Hastings, Ian M, et al.
Publicado: (2014) -
An in silico drug treatment model to assess the robustness of regional age-based dosing regimens for artemisinin-based combination therapies
por: Staehli Hodel, Eva Maria, et al.
Publicado: (2012) -
Improving Pharmacokinetic-Pharmacodynamic Modeling to Investigate Anti-Infective Chemotherapy with Application to the Current Generation of Antimalarial Drugs
por: Kay, Katherine, et al.
Publicado: (2013) -
Optimizing the programmatic deployment of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine using pharmacological modelling
por: Hodel, Eva Maria, et al.
Publicado: (2014)